评估 Avipattikar churna 与 Chitrakadi kwath 在治疗 Amlapitta(胃酸过多)方面的疗效 - 一项试点研究

IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
I. Gaikwad, Sadhana Misar Wajpeyi
{"title":"评估 Avipattikar churna 与 Chitrakadi kwath 在治疗 Amlapitta(胃酸过多)方面的疗效 - 一项试点研究","authors":"I. Gaikwad, Sadhana Misar Wajpeyi","doi":"10.47552/ijam.v15i2.4587","DOIUrl":null,"url":null,"abstract":"Amlapitta is a condition characterised by the predominance of Pitta and is associated with the Annavaha and Purishvaha srotas. It manifests as a result of imbalances in Mandagni (weakened digestive fire) and the presence of Ama (undigested or improperly metabolized substances). The prevalence rate of Amlapitta in India is 38.1%. Considering the similarities in etiopathogenesis, it can be correlated with Hyperacidity in Modern Science. Aim and Objectives: To evaluate the efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity). Methodology: An Interventional Study was conducted among 30 patients between the ages of 20 and 60 of either sex who had symptoms of Tikta Amlodgar (sour and bitter irructation), Hrit-kanthadaha (burning in heart and throat), Udarashool (epigastric pain) and Utklesha (nausea),  and Aruchi (anorexia). Group A was given Aipattikar Churna; Group B was given Chitrakadi Kwath. Subjective Parameters were assessed in both groups on the 0th, 7th, and 15th days, and comparison was done by statistical analysis. Observation and Discussion: Both interventions proved effective, showcasing strengths in addressing distinct subjective parameters. Conclusion: Both drugs demonstrated high effectiveness in the study. Group A exhibited significant improvements across all subjective parameters, except Udarshoola (Abdominal pain). On the other hand, Group B displayed notable results in all subjective parameters, except for Utklesha and Aruchi. In conclusion, both groups were significant.","PeriodicalId":13751,"journal":{"name":"International Journal of Ayurvedic Medicine","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity) - A pilot study\",\"authors\":\"I. Gaikwad, Sadhana Misar Wajpeyi\",\"doi\":\"10.47552/ijam.v15i2.4587\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Amlapitta is a condition characterised by the predominance of Pitta and is associated with the Annavaha and Purishvaha srotas. It manifests as a result of imbalances in Mandagni (weakened digestive fire) and the presence of Ama (undigested or improperly metabolized substances). The prevalence rate of Amlapitta in India is 38.1%. Considering the similarities in etiopathogenesis, it can be correlated with Hyperacidity in Modern Science. Aim and Objectives: To evaluate the efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity). Methodology: An Interventional Study was conducted among 30 patients between the ages of 20 and 60 of either sex who had symptoms of Tikta Amlodgar (sour and bitter irructation), Hrit-kanthadaha (burning in heart and throat), Udarashool (epigastric pain) and Utklesha (nausea),  and Aruchi (anorexia). Group A was given Aipattikar Churna; Group B was given Chitrakadi Kwath. Subjective Parameters were assessed in both groups on the 0th, 7th, and 15th days, and comparison was done by statistical analysis. Observation and Discussion: Both interventions proved effective, showcasing strengths in addressing distinct subjective parameters. Conclusion: Both drugs demonstrated high effectiveness in the study. Group A exhibited significant improvements across all subjective parameters, except Udarshoola (Abdominal pain). On the other hand, Group B displayed notable results in all subjective parameters, except for Utklesha and Aruchi. In conclusion, both groups were significant.\",\"PeriodicalId\":13751,\"journal\":{\"name\":\"International Journal of Ayurvedic Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2024-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Ayurvedic Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47552/ijam.v15i2.4587\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Ayurvedic Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47552/ijam.v15i2.4587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

阿姆拉皮塔(Amlapitta)是一种以皮塔(Pitta)为主的病症,与安纳瓦哈(Annavaha)和普里什瓦哈(Purishvaha)两种体质有关。它表现为 Mandagni(消化系统火力减弱)失衡和 Ama(未消化或代谢不当的物质)的存在。在印度,Amlapitta 的发病率为 38.1%。考虑到发病机理的相似性,现代科学可将其与胃酸过多联系起来。目的和目标评估 Avipattikar churna 与 Chitrakadi kwath 在治疗 Amlapitta(胃酸过多)方面的疗效。研究方法:对 30 名年龄在 20 岁至 60 岁之间、有 Tikta Amlodgar(酸苦虹吸)、Hrit-kanthadaha(心脏和喉咙灼热)、Udarashool(上腹痛)、Utklesha(恶心)和 Aruchi(厌食)症状的男女患者进行干预研究。A 组服用 Aipattikar Churna;B 组服用 Chitrakadi Kwath。在第 0 天、第 7 天和第 15 天对两组的主观参数进行评估,并通过统计分析进行比较。观察和讨论:事实证明,两种干预方法都很有效,在解决不同的主观参数方面都有优势。结论:两种药物在研究中都表现出很高的有效性。A 组除 Udarshoola(腹痛)外,所有主观指标均有明显改善。另一方面,B 组除 Utklesha 和 Aruchi 外,在所有主观参数方面都有显著效果。总之,两组的效果都很明显。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity) - A pilot study
Amlapitta is a condition characterised by the predominance of Pitta and is associated with the Annavaha and Purishvaha srotas. It manifests as a result of imbalances in Mandagni (weakened digestive fire) and the presence of Ama (undigested or improperly metabolized substances). The prevalence rate of Amlapitta in India is 38.1%. Considering the similarities in etiopathogenesis, it can be correlated with Hyperacidity in Modern Science. Aim and Objectives: To evaluate the efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity). Methodology: An Interventional Study was conducted among 30 patients between the ages of 20 and 60 of either sex who had symptoms of Tikta Amlodgar (sour and bitter irructation), Hrit-kanthadaha (burning in heart and throat), Udarashool (epigastric pain) and Utklesha (nausea),  and Aruchi (anorexia). Group A was given Aipattikar Churna; Group B was given Chitrakadi Kwath. Subjective Parameters were assessed in both groups on the 0th, 7th, and 15th days, and comparison was done by statistical analysis. Observation and Discussion: Both interventions proved effective, showcasing strengths in addressing distinct subjective parameters. Conclusion: Both drugs demonstrated high effectiveness in the study. Group A exhibited significant improvements across all subjective parameters, except Udarshoola (Abdominal pain). On the other hand, Group B displayed notable results in all subjective parameters, except for Utklesha and Aruchi. In conclusion, both groups were significant.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Ayurvedic Medicine
International Journal of Ayurvedic Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
50.00%
发文量
87
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信